PTC THERAPEUTICS, INC.
Ticker: 1070081
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 272.55+29.2% | 211.01+18.0% | 178.88-84.8% | 1.2K+497.6% | 196.79+5.4% | 186.70-11.1% | 210.12+6.9% | 196.58 |
| Total Income | 272.55+29.2% | 211.01+18.0% | 178.88-84.8% | 1.2K+497.6% | 196.79+5.4% | 186.70-11.1% | 210.12+6.9% | 196.58 |
| EXPENSES | ||||||||
| Expenditure | 227.59+9.4% | 207.99-2.7% | 213.83+3.9% | 205.87-18.1% | 251.30+10.7% | 226.92-11.2% | 255.57-18.8% | 314.74 |
| Tax | 0.35+100.9% | -38.97-528.5% | -6.20-109.8% | 63.27+630.6% | 8.66-35.6% | 13.45+95.5% | 6.88+120.5% | -33.62 |
| PROFIT | ||||||||
| PBT | -2.46+89.3% | -23.07+67.5% | -71.05-107.6% | 929.83+1048.9% | -97.99-14.3% | -85.73-1.2% | -84.70+49.2% | -166.59 |
| Net Profit | -2.81-117.7% | 15.90+124.5% | -64.85-107.5% | 866.56+912.5% | -106.65-7.5% | -99.18-8.3% | -91.58+31.1% | -132.97 |
| KEY METRICS | ||||||||
| OPM % | 16.50%+15.07pp | 1.43%+20.97pp | -19.54%-102.04pp | 82.50%+110.20pp | -27.70%-6.16pp | -21.54%+0.09pp | -21.63%+38.48pp | -60.11% |
| NPM % | -1.03%-8.56pp | 7.53%+43.79pp | -36.25%-109.94pp | 73.68%+127.88pp | -54.20%-1.08pp | -53.12%-9.54pp | -43.58%+24.06pp | -67.64% |
| EPS | -0.03-115.0% | 0.20+124.1% | -0.83-107.5% | 11.09+897.8% | -1.39-7.8% | -1.29-7.5% | -1.20+31.8% | -1.76 |
Corporate Events
Board MeetingPTCT
20268Jun
Board Meeting
Director Resignation and Consulting Agreement — Alethia Youn…
SEC Filing ↗ Board MeetingPTCT
20262Jun
Board Meeting
Annual Meeting of Stockholders to elect Class I directors, r…
SEC Filing ↗